HP and Cognitive impairment: Previous studies found increased plasma and brain haptoglobin levels in AD patients compared to controls (Song et al., 2015; Philbert et al., 2021) and an association between haptoglobin levels and the severity of cognitive impairment (Zhu et al., 2018).